Iradimed (IRMD) Change in Receivables (2013 - 2026)

Iradimed (IRMD) has 14 years of Change in Receivables data on file, last reported at -$212000.0 in Q1 2026.

• On a quarterly basis, Change in Receivables fell 109.93% year-over-year to -$212000.0 in Q1 2026; TTM through Mar 2026 was $680000.0, a 273.77% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 271.79% from the prior year.
• Change in Receivables for Q1 2026 stood at -$212000.0, down from -$191434.0 in the prior quarter.
• Over the last five years, Change in Receivables for IRMD reached as high as $2.9 million in Q3 2025 and fell as low as -$1.8 million in Q2 2025.
• Historically, Change in Receivables has averaged $497163.4 across 5 years, with a median of $188885.0 in 2024.
• Across the five-year window, Change in Receivables surged 15386.55% in 2022 and slumped 213.03% in 2023, its largest moves.
• Year by year, Change in Receivables stood at $2.7 million in 2022, then slumped by 118.68% to -$498857.0 in 2023, then soared by 137.86% to $188885.0 in 2024, then slumped by 201.35% to -$191434.0 in 2025, then declined by 10.74% to -$212000.0 in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were -$212000.0 in Q1 2026, -$191434.0 in Q4 2025, and $2.9 million in Q3 2025.